Don’t miss action in this small-cap pharma stock that announced stock split after reporting a 36 per cent jump in net profit; know the record date!
Don’t miss action in this small-cap pharma stock that announced stock split after reporting a 36 per cent jump in net profit; know the record date!

Don’t miss action in this small-cap pharma stock that announced stock split after reporting a 36 per cent jump in net profit; know the record date!

The stock is up by 45 per cent in just 3 months whereas the BSE Sensex Index is 5.97 per cent.

DSIJ Intelligence-1 Article rating: 4.3

The net sales increased by 20.80 per cent to Rs 302 crore and net profit increased by 10 per cent to Rs 44 crore in FY23 over FY22.

52-week high alert: Heavy buying in this small-cap stock as the company announces stellar results and stock split!
52-week high alert: Heavy buying in this small-cap stock as the company announces stellar results and stock split!

52-week high alert: Heavy buying in this small-cap stock as the company announces stellar results and stock split!

The stock is up by 21 per cent in just 1 month and over 50 per cent in 3 months.

DSIJ Intelligence-1 Article rating: 3.9

The shares of the company have a PE of 20x, an ROE of 18 per cent and a ROCE of 21 per cent. The net sales increased by 20.80 per cent to Rs 302 crore and net profit increased by 10 per cent to Rs 44 crore in FY23 over FY22.

Don’t miss action in this small-cap stock that is likely to announce stock split!
Don’t miss action in this small-cap stock that is likely to announce stock split!

Don’t miss action in this small-cap stock that is likely to announce stock split!

The stock is up by 24.15 per cent in just 1 month.

DSIJ Intelligence-1 Article rating: 3.6

The company reported positive numbers in its quarterly results & annual results and has delivered good profit growth of 44.50 per cent CAGR over the last 5 years. The net sales increased by 20.80 per cent to Rs 302 crore and net profit increased by 10 per cent to Rs 44 crore in FY23 over FY22.

Don’t miss action in this small-cap stock that announces issuance of convertible warrants on preferential allotment!
Don’t miss action in this small-cap stock that announces issuance of convertible warrants on preferential allotment!

Don’t miss action in this small-cap stock that announces issuance of convertible warrants on preferential allotment!

The stock is up by 30 per cent in just 1 month and over 40 per cent in 3 months.

DSIJ Intelligence-1 Article rating: 4.3

The shares of the company have a PE of 20.80x, a ROE of 18 per cent and a ROCE of 21 per cent. The company reported positive numbers in its quarterly results & annual results and has delivered good profit growth of 44.5 per cent CAGR over the last 5 years.

RSS
1234

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR